Patent 8613703
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Abbott Diabetes Care Inc.
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
A search of publicly available PTAB databases and dockets as of May 29, 2026, indicates there are no AIA trial proceedings on file for US Patent 8613703. This means the patent has not been subjected to inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) review. Therefore, all claims of the patent remain untested in the PTAB context, and a defendant's defensive posture would need to consider the patent as unhardened by PTAB trials.
Strategic summary
As there are no PTAB proceedings on file for US8613703, all claims (1-24) of the patent remain untested and are currently considered valid as issued by the USPTO. This patent has not been subjected to the scrutiny of an AIA trial.
Since no PTAB proceedings have been initiated, there is no estoppel landscape to consider under § 315(e)(2). All prior-art grounds remain available for a potential defendant to raise, whether in district court litigation or a future PTAB petition, subject to statutory time bars (e.g., one year from service of a complaint for IPR).
The absence of PTAB activity is a notable signal. Patents that are actively asserted, particularly against multiple parties, often attract IPR filings. The lack of such filings might suggest that the patent has not been extensively asserted in litigation that would trigger IPR challenges or that previous assertions were resolved without PTAB involvement.
Recommended next steps
Since no PTAB activity exists for US8613703, the primary recommendation is to conduct a thorough prior art search to assess the patent's validity independently. If facing an assertion, this search would help determine the strength of any potential invalidity arguments and whether to consider filing a new IPR petition, subject to the statutory time limits. The absence of PTAB activity means there are no existing PTAB decisions to leverage or appeal.
Generated 5/29/2026, 8:56:00 PM